World Organization For Animal Health Says Germany Reports Outbreak Of Highly Pathogenic H5N1 Bird Flu On Farm In Eastern Part Of The Country
Here Are the Medicare Part D Drugs Expected to Face 2025 Price Negotiations
European luxury goods concept stocks saw the largest weekly increase since 2012.
On Friday, September 27, the personal and household products index of the STOXX 600 index rose by 1.77%, marking a fifth consecutive trading day increase, with a total surge of 9.38% for the week. Data shows that among the component stocks, Henkel rose by 10.91% on Friday, Beiersdorf by 6.96%, Yunji Group by 6.34%, Ubisoft Entertainment by 5.94%, and Hugo Boss by 5.45% ranking fifth in performance, while LVMH Group rose by 3.67% ranking ninth in terms of increase. Meanwhile, L'Oreal dropped by 0.66%, marking the largest decrease among the three component stocks that fell. Among the "EU Eleven Heavenly Kings," Novo-Nordisk A/S dropped by 4.59%, while L'Oreal...
Unusual Options Activity: UBER, MMM and Others Attract Market Bets, UBER V/OI Ratio Reaches 615.4
EST Sep 26th Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
Analysts Offer Insights on Healthcare Companies: GlaxoSmithKline (GB:GSK), Sonova Holding AG (Six Swiss: CH:SOON) and Corbus Pharmaceuticals (CRBP)
Biogen (BIIB.US) and UCB's lupus new drug, daclizumab, late-stage trial successful, reversing early failures.
On Tuesday, BaiHealth and its Belgian partner UCB announced that the experimental lupus treatment drug Darzalex achieved the main goal in late-stage trials.